Emerging Biopharma
Flexible solutions. Responsive teams. Data-driven insights.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgique
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
-
Patient Engagement
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
Advance your patient engagement strategy
Discover new patient engagement possibilities with IQVIA insights, expertise, and technology-driven solutions.
Patient Engagement OverviewPatient Engagement Quick Links
- Commercial Engagement Solutions
- Commercial Patient Engagement Suite
- eCOA
- Clinical Outcome Assessment (COA) instrument library
- Linguistic Validation
- Patient-Centered Endpoints
- Engagement Services (US)
- Association Management
- Recruitment
- Journey Analytics
- Patient Finder
- Disease insights
- Disease Registries
- Treatment satisfaction
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Future Innovation in Clinical Development
Highlights from a webinar about global trends in R&D
Apr 08, 2022
The IQVIA Institute for Human Data Science conducted a global webinar on March 30, 2022, which followed the release of a recent IQVIA Institute report on Global Trends in R&D: Overview through 2021.
The webinar included participation from an esteemed group of panelists who contributed to the discussion with insightful perspectives about the current state of and future prospects for biopharmaceutical R&D.
In the course of the webinar, panelists discussed a number of key topics:- The activity-productivity conundrum in clinical drug development: Why is global clinical trial activity at an all-time high while clinical development productivity has been declining? Is the decline in productivity a logical reflection of the historically high intensity of clinical trial activity and the increase in investments to pursue new novel innovations? How can you reduce potential failures “when you are swinging for the fences?”
- Failures rising in Phase III studies: Data in the Global R&D report suggests the number of failures in drug development is increasing in Phase III. How can we advance efforts to assess and predict potential failures already in Phase I and Phase II studies to avoid more costly failures in Phase III?
- Operational challenges in drug development: Panelists discussed a number of operational challenges in drug development, including overload of global trial sites, the war on talent regarding clinical trial professionals, and the difficulties regulatory agency teams are facing to hire experts and keep pace with rapidly changing scientific and technical requirements in the R&D environment. How can the remarkable responses to the pandemic translate to sustainable approaches that can address some of these challenges?
- The growing importance of novel trial designs and trial formats: Decentralized clinical trials and virtualization, master protocols, platform trials, and adaptive trials are all pertinent to this conversation. Where can these designs be most effectively deployed and how can COVID-19-related experiences be further applied?
- Patient diversity and patient-centricity: How do you conduct clinical development in an environment where expectations about patient diversity and more representative patient participation in clinical trials have fundamentally changed? How do you make clinical drug development more patient-centric so that patients and their families can truly understand and relate to the opportunities offered to them through clinical trials as a treatment option?
- Global rebalancing of R&D: How radical will the changes be in the global infrastructure around clinical trials, given the growing requirements for multi-regional studies and data, globalization of clinical trials sites, and rapidly evolving policies in the European Union and China around clinical trial regulations?
- Joseph DiMasi, Ph.D.
Director of Economic Analysis, Tufts Center for the Study of Drug Development -
Cartier Esham, Ph.D.
Chief Science Officer, Biotechnology Innovation Organization -
Tim Opler, Ph.D.
Partner and Co-founder, Torreya Partners - Peter Ronco
Head, Global Development, Janssen -
Mark Trusheim, MSc
Strategic Director, NEWDIGS, MIT Center for Biomedical Innovation
Visiting Scientist, Sloan School of Management, MITv
President, Co-Bio Consulting
Related solutions
Industry Segments
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.